OFalkenberg
TL1 Member · Poznań, PL
Newer member working through the reference pages before asking anything.
Joined 15 December 2024 · last posted 2mo
24Posts here
0Topics
1Solutions
180Likes received
98Likes given
11Badges
80Days visited
1.3kPosts read
Stated areas
Recent activity
Full stream-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #14 · Sourcing › Red flags · 3 Jun 2026 · 28 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Bioimpedance and hydration: why the number moves Replied, post #29 · Outcomes › Body composition · 11 Apr 2026 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #69 · Start Here › How to Ask · 2 Mar 2026 · 24 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #118 · Practice › Interactions · 23 Feb 2026 · 15 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
What to include when your question involves a chromatogram Replied, post #28 · Start Here › How to Ask · 8 Jan 2026 · 0 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #70 · Clinical › Special populations · 7 Jan 2026 · 27 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #121 · Practice › Side effects · 30 Dec 2025 · 3 likes I read post #119 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #20 · Access › International · 21 Dec 2025 · 13 likes Picking up post #17: that is the part I would want checked first. Import rules for personal use: what you can import for personal use depends on your country's rules,…
-
DXA precision and the least significant change for lean mass Replied, post #75 · Outcomes › Body composition · 16 Dec 2025 · 4 likes Worth separating two things that post #71 runs together. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #58 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 3 likes On post #54 — agreed on the reasoning, with one qualification. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms.…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #4 · Practice › Side effects · 28 Sep 2025 · 2 likes post #3 answers the question as asked. The question underneath it is different. Gallbladder complications: rapid weight loss increases the risk of gallstone formation.…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #58 · Practice › Storage & stability · 15 Sep 2025 · 17 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…